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Abstract  
 Background: Ameloblastoma is a benign local aggressiveness 
odontogenic tumor that has great tendency to recur. Aims: characterize the 
staining profiles of various markers in ameloblastoma. 
Materials and methods: immunohistochemical analysis of Ki-67, Bcl2, CD34 
and VEGF and TUNEL assay were performed in 50 ameloblastomas. Mann-
Whiteny and Pearson’s correlation applied for analysis. P < 0.05 was 
considered statistically significant. 
Results: The outer odontogenic epithelial cells of ameloblastoma had low 
Ki-67 labeling index (3.66±4.39) that is significant differed among its 
subtypes, and high Bcl2 expression in all variants (74.39%) and lining cells 
of unicystic ameloblastoma. On the other hand, inner odontogenic epithelial 
cells of ameloblastoma had low apoptotic index mean (3.5%), nevertheless 
high values were observed in acanthomatous (7.76%) and follicular (6.1%) 
subtypes. The mean count of new micro-vessels was (22.4±25.54). They 
were predominantly round-shaped small-sized vessels. VEGF was highly 
expressed in the outer cells, and correlated with microvessels' count 
(r=0.35). VEGF expression did not relate to histological variation.  
Conclusions: Ameloblastomas have high-strong expression for both Bcl2 and 
VEGF in outer tumor cells, and aberrant stromal neo-vascularization, but 
Ki67 expression significantly differed among their variants. Unicystic 
ameloblastoma should be considered with caution, their lining cells showed 
features of aggressiveness. It is recommended to evaluate Bcl2 and MvD to 
predict aggressiveness and VEGF to evaluate potential tumor survival and 
growth that may poses a possible benefit in treatment planes. 
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Introduction 
Ameloblastoma (AB) is a benign odontogenic tumor, with prevalence 
equal to or exceeding the combined total of all other odontogenic tumors 
excluding odontoma. It is usually seen in adults (relatively uncommon in 
teenagers) at posterior mandible [Waldron, 2009 and Rastogi et al, 2010].  
AB is slowly growing, locally aggressive tumor that has great tendency to 
recur if not adequately excised and it has an unpredictable tendency to 
metastasize [Waldron, 2009; Rastogi et al, 2010; Amzerin  et al, 2011; 
Ponniah, 2011]. 
According to the WHO classification, AB had several variants; solid ⁄ 
multicystic (SAB), extraosseous ameloblastoma, desmoplastic and unicystic 
type (UAB), beside malignant ameloblastoma and ameloblastic carcinoma 
[WHO, 2005]. Histologically AB is highly polymorphic, it has the ability to 
undergo various forms of metaplasia (acanthomatous, granulomatous, 
desmoplastic, basaloid, keratoameloblastoma and clear-cell ameloblastoma] 
[Waldron, 2009].  
Molecularly AB gains growth and invasion potential through 
overexpression of TNF-α, anti-apoptotic proteins (Bcl2-Bcl-xL), and 
interface proteins (TGF, matrix metalloproteinase). ABs, however, have a 
low proliferation rate and P53 gene mutation do not appear to play a role 
[Regezi et al, 2008]. Researchers indicated that AB has higher proliferative 
activity than other benign odontogenic tumors [Sandra et al,2001; El Deeb , 
2003; Payeras  et al, 2007; Yu  2007; Gadbail  et al, 2011; Salehinejad etal, 
2011; Razavi  et al, 2012 and Florescu  et al, 2012], that unrelated to its 
clinical behavior [Abdel-Azimet al, 2001 and , Salehinejad et al, 2011], 
although it can be use to differentiate ameloblastic carcinoma from AB 
[Kamath et al, 2010] or primary from recurrent AB [Piattelli  et al, 1988; 
Migaldi  et al, 1998 and Hirayama  et al, 2004]. On the other hand, the 
reported high Bcl2 expression in some studies [Jie Wang et al, 2006 and 
Razavi et al, 2009] was contradict by Mashhadiabbas and Najirad [2007] 
who also stated that Bcl2 can't be used to differentiate among benign, 
malignant or recurrent AB. Furthermore, other researchers did not find 
differences in VEGF expression between SAB and UAB [Handeet al, 2011]. 
Lastly, microvessel density (MvD) were reported to increase gradually in 
primary [Seifiet al, 2011], recurrent and malignant AB [Kumamoto et al, 
2002; Zhong and Wang, 2003].  
This study aimed to characterize the IHC staining profile of different 
types of AB by examines the expression and distribution of Ki-67, Bcl-2, 
CD34 and VEGF beside localization and detection of terminally apoptotic 
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cells, hopping to understand the biological features behind their polymorphic 
metaplasia. 
 
Materials and methods 
A total of 50 formalin fixed paraffin embedded blocks of AB and 
their files were collected from the archives in the Department of Oral 
Pathology/University of Baghdad/College of Dentistry. Serial 4µm sections 
were cut for routine and IHC staining. Cases were re-examined and 
diagnosed according to the WHO [2005]. The study was approved by the 
ethics committee of the college. 
Sections were deparaffinized and rehydrated, for IHC they were 
immersed in antigen retrieval solutions (BioGenex: Citra for Ki-67 and Bcl2, 
Chemicon: EDTA pH 8.0 for VEGF) and subjected to autoclave 
pretreatment at 121 °C (20, 3 and 5 min. for Ki-67, Bcl2 and VEGF 
respectively). For CD34 this step was not recommended. Endogenous 
peroxidase activity was blocked by 0.3% H2O2 (30 min). Then sections 
were incubated with 4 primary monoclonal antibodies; mouse anti Ki-67 
(BGX-297, BioGenex, USA; ready to use; 2hrs at 37°C), mouse anti-Bcl2 
(BioGenex, USA; ready to use; 1hr at 37°C), anti-VEGF 
(Chemicon,Germany,diluted at 1:50, 1hr at 37°C) and mouse anti-CD34 
(ImmunoTech, France, diluted at 1:50, 1hr at 37°C). Section treated with 
secondary antibody for 30 min at 37°C, then allowed to react with 
streptavidin-horseradish peroxidase reagent (BioGenex, B-SA system) or 
streptavidin AP reagent (Chemicon immunophosphatase detection system) 
for 30 min at 37°C, and reaction products were visualized either by 
diaminobendizine (DAB) or fast red chromogen for 20 min then counter 
stained with hematoxylin. Negative control sections were treated with 
phosphate buffer saline (PBS) instead of the primary antibody. 
From each section 5 representative fields were selected and a 
minimum of 1000 positive neoplastic odontogenic epithelial cells were 
evaluated at a magnification of X400.  All slides were assessed blindly by 
two pathologists and the average of readings was obtained. The mean Ki-67 
labeling index (LI) was calculated and the remaining antibodies were 
evaluated semi quantitatively as follows: Bcl2 expression: negative ≤5%; +: 
> 5-20%, ++: > 20-50% and +++: > 50-100% [Chrysomali et al, 2003]. 
VEGF scored as; +: 0-19%, +: 20-39%, ++: 40-59% and +++: 60-100% and 
its intensity assessed as: weak, moderate and strong [Lim et al, 2003]. The 
MvD is equal to the number of CD34 positive vessels in 5 hotspot fields of 
stroma at high power (X400) [Vermeulen et al, 1996]. Additionally the shape 
of microvessels was classified into round and elongated, whereas the size 
was assessed subjectively as small (contain ≤ 3 RBCs or endothelial cell 
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clusters or single cell sprout not luminated) and medium vessels (contain > 4 
RBCs or dilated lumen).  
For detection of apoptotic DNA fragmentation ApopTag plus 
peroxidase in situ apoptotic detection kit code S7101 (Chemicon, Germany) 
was used. New sections were deparaffinized, then treated with 20µg/ml 
proteinase K (15 min) and with 3% H2O2 in PBS to eliminate endogenous 
peroxidase activity. Subsequently they were incubated with TdT (1hr, 37°C) 
followed by anti-digoxigenin conjugate (30 min).Then immersed in a 0.03% 
DAB (3 min) and counterstained with methyl green, finally  dehydrated and 
mounted. 
Apoptosis index (AI) from 5 randomly selected representative fields 
at high power (X400) was performed. The stage of apoptosis depending on 
nuclear morphology of positive cells was identifying as: early staged: round 
nuclei with chromatin margination; middle stage: condensed nuclei; and late 
stage: nuclear fragmentation (apoptotic bodies) at (X1000). 
 SPSS statistical software was used to perform Mann-Whiteny test 
and Pearson's correlation coefficient. Probabilities of less than 0.05 were 
accepted as significant.  
 
Results 
AB occurred in patients aged between 5-85 years, predominantly in 
males, at posterior region of the mandible (94%).  24 cases were SAB and 26 
cases were UAB (16 cases of them had mural growth).  
Nuclear Ki-67 positivity was detected in 88% of the cases, 
predominately at outer cells with 3.66±4.39 LI (table-1). Ki-67 expression 
was less in females and it correlated with age (r=0.3, p=0.018) (table2). Ki67 
expression significantly differed among AB variants (table 3).The highest 
value was reported in basal type (15.45) (figure-1A). Follicular islands 
whether they were in SAB or in mural growth of UAB (figure-1B) showed 
similar Ki-67 expression.  
Ameloblastomas showed high cytoplasmic Bcl2 expression (74.39%) 
with strong intensity at the outer cells in all cases, particularly in follicular 
SAB (75.8, figure-1C), mural islands of UAB (84.1, figure-1 D) and lining 
cells of UAB (73.0). Almost all inner cells had low (23.62) and weak Bcl2 
expression (table1), except those in acanthomatous variant (table-3). Male 
patients had significantly higher Bcl2 expression at both the inner (22.5, 
P=0.02) and lining cells (76.73, P=0.03). Patients with age ≤20 had lowest 
Bcl2 positivity (10.8±15.7) in inner cells. Bcl2 expression significantly 
correlated with Ki-67 at outer cells (r= -0.45) and in UAB it had stronger 
correlation at both outer and lining cells (r=-0.63, r=-0.66 respectively). Thus 
UAB differ from other variants by strongly maintaining cells surviving in 
different compartment; mural and lining. 
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TUNEL reaction was positive in 44 (88%) cases predominantly in 
inner cells (3.5±3.39, figure-1E) and to lesser extent in lining cells of UAB 
(1.35±1.17) (table 1).The later showed high AI in females (2.1±1.3) and in 
patients older than 40years (2.06±1.72, table2). Histologically, 
acanthomatous (figure-1F) and plexiform AB expressed significantly high 
AI, especially when compared with mural islands of UAB (7.76, P=0.026 
and 6.1, P= 0.045 respectively versus 1.58). Desmoplastic variant did not 
express TUNEL staining (table-3). Concerning stage of cell death, 
acanthomatous AB had high number of cells at late fragmentation stage 
(46.33%), while plexiform showed more cells at early stage of apoptosis 
(margination, 43.33%, p=0.01). The remaining variants were in mixed stages 
of cell death (table 3). AI correlated with Bcl2 at inner cells, outer cells and 
lining cells (r=-0.814, r= -0.43 and r=-0.99 respectively). 
VEGF showed significant high positive cytoplasmic and membranous 
expression with strong intensity in outer and lining tumor cells as well as in 
endothelial cells in all cases. Patients with >40 years old showed 
significantly less expression with weak intensity in lining cells of UAB 
(69.13, P=0.031) and in inner cells (9.16, P=0.05) respectively (Table 2). 
VEGF positivity in the outer cells did not differ among AB variants 
(figure-2A), and the highest positivity was recorded in mural islands of UAB 
(93.7, table 3), while its intensity was almost strong except in plexiform and 
lining cells of UAB they were of moderate intensity (66.7%, and 52%, 
respectively, P<0.05). Regarding the inner cells, squamous metaplastic cells 
had significantly highest positivity (55) with 100% strong intensity. 
VEGF expression correlated with Ki-67 expression at both the outer 
(r=0.34, p=0.05) and inner cells(r= -0.991, p=0.00) and with Bcl2 at inner 
cells (r=0.423, p=0.05).   
The mean count of new microvessels (MvD) in AB was (22.4±25.54). 
They were predominantly round-shaped vessels and small-sized (table 4, 
figure-2B) with no statistical sex differences. Patients below 20 years old 
expressed significantly the highest MvD around tumor islands than other age 
groups (35.97±47.7, P=0.03, table 2). 
The mean MvD did not differ among SAB variants (table3), but the 
single case of desmoplastic AB showed very high number of small vessels.  
Whereas plexiform AB showed significantly fewer small vessels (3±1.99, 
P=0.02), and had elongated medium size vessels (table 3).  
MvD around tumors’ islands correlated significantly at outer cells with 
the expression of Ki-67 (r=0.45, p=0.014) and Bcl2 (r=0.5, p=0.042) and it 
correlated significantly with AI at inner cells (r= -0.319, p=0.05). The 
microvessels’ size correlated with Bcl2 expression at outer cells of SAB 
islands (r=0.56, p=0.03) and lining cells of UAB (r=0.567, p=0.04). The 
number of round shape new vessels correlated with VEGF expression in 
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outer cells (r=0.32, p=0.035) of ameloblastic islands and lining cells of UAB 
(r=0.357, p=0.037). 
 
Discussion 
Ameloblastomas deserves special attention, not only because of its 
particular biological behavior but also due to its relatively high frequency 
among odontogenic tumors. Estimation of IHC staining profile in different 
AB variants could be helpful in understanding the biological features behind 
their polymorphic metaplasia, and may poses a possible benefit in treatment 
planes or establishment of prognostic value in the future.  
Similarly to previous studies [Sandra et al, 2001; Razavi et al 2012; 
Florescu et al, 2012; Amaral et al, 2012] we indicate that the majority of AB 
had low Ki-67 LI (3.66) and it was lesser than that reported by Abdel Aziz 
(8.29 ± 3.15) [Abdel-Aziz and Amin 2012] who remarked to even a higher 
LI in recurrent cases (LI=19). Furthermore females and younger age patients 
expressed lower proliferative activity. These results support Sandra et al 
[2001] findings that lowest values being present in young patients and vice 
versa. 
We agree with previous reports that the cellular proliferation and 
consequently AB growth are related to outer cells [Sandra et al, 2001; 
Bologna-Molina et al, 2008; Florescu et al, 2012, Amaral et al, 2012; Abdel-
Aziz and Amin, 2012] and that follicular AB has higher Ki-67 expression 
than plexiform [Sandra et al, 2001;  Kumamoto et al, 2002; Yu, 2007; 
Florescu et al, 2012], but we contradict, Florescu et al [2012] by observing 
Ki-67 expression in granular AB. Furthermore, this study showed a high Ki-
67 expression in both basal and acanthomatous AB, and almost scant 
proliferation in desmoplastic AB (although cases number was limited). Thus 
proliferation assessment may be related to epithelial island size rather than 
related to its aggressiveness. On the other hand, UAB had lower proliferative 
activity than SAB, but it become identical or slightly higher than follicular 
AB when it had mural growth. This explains why Bologna-Molina et al 
[2008] found both types had nearly similar proliferative activity. Yet other 
studies did not correlate Ki-67 expression with AB variants [Mashhadiabbas 
et al, 2007, Migaldi et al, 2008; Bello et al, 2009] but rather related it to 
relapses [Migaldi et al, 2008]. 
 Accordingly AB showed limited proliferative activity if compared to 
its clinical locally invasive behavior, support the concept that infiltrating 
potential of AB is not related to the cellular proliferation index [Abdel-Azim 
et al, 2001, Bello et al, 2009; Salehinejad et al, 2011]. This will not denote 
such index may be higher if samples are taken selectively from invasive front 
or designing long cohort studies to confirm its causal relationship with 
clinical behavior.  
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Bcl2 expression was observed in 100% of cases, predominantly at 
outer cells with greater positivity and strong intensity than previous reported 
(50% and 88.2%) [Luo et al, 2006; Florescu et al, 2012]. While, AI for 
terminal apoptotic cells was observed in 88% in the inner cells. In contrast to 
our results, Amaral et al [2012] demonstrated more apoptotic cells in outer 
cells than in inner areas of AB and at much higher level 3.5 versus 18.8. We 
found an inverse correlation between AI and Bcl2 expression, but both of 
them had no relation with sex or age variation.  
 Although it is believed that UAB has an innocent behavior, in this 
study however, its outer and lining cells seems to resist apoptosis by 
harboring great  Bcl2 expression than plexiform, basaloid and the 
acanthomatous AB. Furthermore, outer cells of mural islands process even 
higher and strong Bcl2 expression than follicular and plexiform.  Inner cells 
of SAB generally express moderate and weak Bcl2, but at early squamous 
metaplasia (without keratin) they showed high expression, that changed to be  
scant and associated with high AI when they become well keratinized 
(indicating their death). On the other hand, granular transformed cells 
showed many apoptotic cell fragments with condensed nuclei suggesting 
great late stage of cell death that associated with phagocytosis by 
neighboring neoplastic cells. This observation coincides with Kumamoto et 
al [2001] but contradict Florescu et al [2012] who did not report Bcl2 
expression in granular or squamoid cell . Lastly, Mashhadiaddas et al [2007] 
could not use Bcl2 to differentiate between different AB variants and Luo  et 
al [2006] did not attributed Bcl2 over expression to AB aggressiveness or 
recurrent behavior.  
Few studies were available concerning angiogenesis in AB. In this 
study, AB showed strong and high VEGF expression in outer cells of all AB 
variants with weak positivity in inner cells. Males and old patients had lower 
VEGF expression at inner and lining cells of SAB and UAB respectively. On 
the other hand, endothelial cells of the microvessels showed weak VEGF 
expression. This indicate that odontogenic epithelia induce angiogenesis, via 
paracrine mechanism [Kumamoto et al, 2002] and play a critical role in 
tumor growth and it might also work as an autocrine growth factor, if it is 
proved to have VEGFR. Inner cells with squamous metaplasia expressed the 
highest VEGF with strongest intensity while inner cells in basaloid, 
desmoplastic, granular and UAB showed lest positivity thus contradict 
Kumamoto et al [2002] results who stated that keratinizing and granular cells 
in AB showed low VEGF expression. Furthermore, mural islands in UAB 
showed over expression of VEGF in the outer cells. 
The current study also illustrated that MvD in tumor stroma was 
higher than that reported around tooth germ (unpublished data) and related to 
VEGF expression, just in line with Kumamoto et al [2002] and Zhong study 
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[2003]. It also confirms that increase MvD is important in AB progression 
and invasiveness [Gadbail et al, 2012] in all histological variant irrespective 
to sex and age. Therefore measurement and assessment of angiogenesis in 
AB can be valuable in predicting response to antiangiogenic therapeutic 
strategies and also provide objective assessment of post therapeutic response. 
Such therapy may aid in the regression of the tumor mass and preventing 
expansion, so decreasing the chance for aggressive radical treatment and 
reducing the risk of disability. 
Furthermore, aberrant neo-vasculaization is reported in this study in 
AB stroma, thus confirm Gadbail et al [2012] observation for the evidence of 
slightly dilated and tortuous microvessels. Similar to Seifi et al [2011], but in 
contrast to Kumamoto et al [2002] findings, there were noticeable 
differences in both MvD and blood vessel size between follicular and 
plexiform AB. Microvessels were numerous, rounded and small in follicular 
AB, whereas, they were elongated of medium size in plexiform. Basal cell 
AB showed diffused expression of VEGF in most tumor cells, despite the 
MvD was fewer than other subtypes; the latter finding was similar to Seifi 
[2011]. Therefore, the expression of CD34 and assessment of MvD may be 
determining factors in prognosis and prediction of AB progress. 
This study indicated that VEGF is highly correlated with Ki-67 expression at 
outer cells, and with Bcl2 at inner cells.  
In conclusion most variant of AB characterized by low Ki-67 
expression (limited growth) and high-strong expression for Bcl2 and VEGF 
(great tumor cells’ survival) at outer cells of tumor islands.  According to 
correlations' results, increase VEGF leads to inhibition of apoptosis, through 
the induction of expression of anti apoptotic protein bcl2 (even in inner cells) 
with increase in the proliferative activity of the outer cells that secrete this 
growth factor, and induct the formation of more blood vessels in the stroma. 
More blood vessels, may further exaggerate the picture, if they are well 
established as numerous luminated vessels and then they further will increase 
the proliferation in the outer cells as well as increase survival of the outer 
and inner cells and reduce death of cells. In spite of that, outer cells neither 
die nor proliferate and maintain tumor mass survival. Therefore, it is 
recommended to evaluate Bcl2 positivity and intensity in tumor cells with 
MvD around tumor islands instead of looking for proliferation. Further 
comparison with other odontogenic neoplasm beside clinical data (recurrence 
or high grade transformation) the above parameters may give more practical 
value. 
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Table 1: The mean immunohistochemical expression of positive markers in ameloblastoma 
at different localization 
 
 
Table (2) Mean of immunohistochemical expression of positive markers in ameloblastoma 
in relation to sex and age  
  
Sex P 
val
ue 
Age P 
valu
e Male Females <20 21-40 >40 
Ki67 
Outer 4.11±5.22 
2.78±1.8
5 
 
2.63±2.0
9 3.4±5.18 4.3±4.02 
 Inner 0.25±0.12 0.42±0.1 0 
0.03±0.0
9 0 
Linin
g 
1.05±1.3
9 1.3±1.58 1±0.78 
0.99±1.0
3 
1.21±2.0
6 
Bcl2 
Outer 73.17±18.46 
74.07±15
.73  
72.17±18
.65 
73.21±19
.33 
73.7±14,
94  
Inner 22.56±18.28 
12.92±13
.39 
0.0
2 
10.8±14.
75 
22.19±17
.51 
25.6±16.
81  
Linin
g 
76.73±17
.9 68±13.49 
0.0
3 
73.43±18
.56 
73.34±16
.65 70±15.17  
VEG
F 
Outer 83.95±13.4 
79.53±18
.25  
84.11±14
.52 
77.87±16
.4 
85.7±12.
55  
Inner 14.28±12.6 
29.28±15
.39  
27.5±12.
52 
21.81±15
.85 
9.16±11.
14 0.05 
Linin
g 69.13±14 82.72±14  
74.14±15
.83 72±14.23 
69.13±12
.51 
0.03
1 
TUN
EL 
Outer 1.5±1.55 0.7±0.6  0.3 1.2± 1.018 0  
Inner 3.68±3.31 
3.26± 
3.58  
4.33±5.3
2 
2.96 
±1.81 
3.78 
±3.88  
Linin
g 0.6±0.57 2.1±1.31 
0.0
5 
0.66 
±0.61 1.3±1.1 
2.06±1.7
2  
CD34 
Arou
nd 
island 
25.36±31
.06 
16.86±6.
7  
35.97±47
.7 
17.99±9.
51 
16.48±3.
9 0.03 
Arou
nd 
lining 
13.01±4.
04 
13.16±4.
2  
11.6±2.6
5 
13.03±3.
89 
13.63±4.
61  
 
 
 No Ki-67 P value 
Bcl2 
100% P value 
TUNEL 
88% P value 
VEGF 
100% 
P 
value 
Outer 50 3.66±4.3 0.000
1 
74.39±1
6.6 0.001 
0.99±0.99 
0.01 
81.7±
15.5 0.02 
Inner 50 0.03±0.11 
23.62±2
2.8 3.5±3.39 
31.89
±15.1 
Lining 26 1.15±1.44 73.04±16.5  1.35±1.17 74.88±14.7 
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Table 3: The mean immunohistochemical expression of positive markers in different 
ameloblastoma’s histological subtypes at different cell locations 
  
Follicul
ar 
(11) 
Plexifor
m 
(6) 
Acanth
o 
(3) 
Basal 
(2) 
Des
mo 
(1) 
Gran
ular 
(1) 
Mural 
islands 
UAB ( 
19) 
P 
val
ue 
Ki
67 
Outer 2.85±1.9 
1.5±1.0
7 
9.36±2.
27 
15.45±
10.67 0.9 1.4 
2.97±3.
48 
0.0
3 
Inner 0.08±0.19 0 0 0 0 1.3 0  
Bcl
2 
Outer 75.8±16.1 
56±13.
8 
55±2.1
2 50±18 70 60 
84.1±1
0.57 
0.0
2 
Inner 17.3±11.9 
13.8±1
4.5 50±18 
27.5±0
3.5 30 40 
26±15.
6 
 VEGF 
Outer 89.36±18.12 
87.5±1
6.4 
76.33±
3.21 
75±21.
12 85 65 
93.76±
12.05 
Inner 39±15.11 
35±14.
15 
55±13.
22 20 25 23 
26.25±
13.14 
TU
N
EL
 
Outer 0.85±0.77 
1.95±1.
9 0 0 0 0 
0.62±0.
54 
Inner 3.65±2.85 
6.1±5.4
8 
7.76±1.
9 2.95 0 3.4 
1.58±1.
43 
0.0
3 
St
ag
e 
Early 13.36±18.71 
43.33±
37.75 
19±24.
75 
16±4.2
4 0  
15.22±
12.33  
Mi
ddl
e 
7±15.5
4 
4.33±6.
74 
12.33±
21.36 0 0 3.4 
4.41±3.
34  
Lat
e 
15. 
±21.79 
19.66±
18.55 
46.33±
7.57 
13.5±1
9.09 0  
14.55±
7.28 
C
D
34
 
Count 20.61±10.58 
40.11±
67.43 
16.67±
1.44 
16.4±1
2.44 38.8 8.4 
19.25±
5.97 
 Round 19.36±9.78 
12.2±1
6.4 
15.86±
2.83 
14.8±1
0.18 38.8 8.4 
18.82±
4.76 
Elongat
e 
11 ± 
0.56 15±14 2.4±0    
8.43±6.
83 
Small 15.83±10.17 3±1.99 
16.00±
2.6 
15.2±1
0.74 25.8 8.4 
17.6±5.
77 
0.0
2 
medium 7.22±2.41 
17.5±2
2.4 2±0 2.4±0 13  
7.42±5.
22  
 
Table (4) Mean count, shape and size of CD34 positive microvessels around solid, mural 
and lining odontogenic epithelial tumor cell in ameloblastoma. 
Histological No Count 
Shape Size 
Round Elongated Small Medium 
Total 50 22.4±25.54 18.42±  8.9 10.29±12.04 15.33±8.21 9.68±11.84 
Lining 26 13.07±4.04 12.42±4.33 4.33±4.74 11.67± 4.7 4.17±1.65 
Mural 19 19.25±5.97 18.82±4.76 8.43±6.83 17.6±5.77 7.42±5.22 
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Figure 1: Immunohistochemical reactivity in odontogenic epithelium cells. Ki-67expression  
in basal ameloblastoma (A) and unicystic ameloblastoma (B)(X200). Bcl2 reactivity in 
outer cells and inner cells of follicular ameloblastoma (C, X200) and in lining and 
mural islands of unicystic ameloblastoma (D, X40). Positive TUNEL reaction in 
apoptotic cells (arrows) in the inner cells of follicular (E) and acanthomatous 
ameloblastoma (F) (X200). 
 
 
 
  A   B 
Figure 2. Immunohistochemical reactivity for vascular endothelial growth factor in the 
outer cells of follicular ameloblastoma (A) and in the neighboring vessels of tumor 
stroma (arrowheads). (B) Immunohistochemical positive reactivity for CD34 in 
microvessels of surrounding stroma (X400). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
